HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -78.3% | 8,000 | -73.6% | 0.00% | -100.0% |
| Q3 2021 | $46,000 | -23.3% | 30,300 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $60,000 | +3.4% | 30,300 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | -32.6% | 31,300 | -20.4% | 0.00% | -50.0% |
| Q4 2020 | $86,000 | -11.3% | 39,300 | +16.3% | 0.01% | -33.3% |
| Q2 2020 | $97,000 | +56.5% | 33,800 | -2.9% | 0.01% | +28.6% |
| Q1 2020 | $62,000 | -11.4% | 34,800 | +165.4% | 0.01% | +40.0% |
| Q4 2019 | $70,000 | – | 13,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |